Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024
Compare Balance Sheet Results of Krebs Biochem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
21.56
11.04
10.52
95.29%
Share Warrants & Outstandings
Total Reserve
-167.80
116.81
-284.61
-243.65%
Shareholder's Funds
-146.24
127.85
-274.09
-214.38%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
161.25
0.00
161.25
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
161.25
0.00
161.25
0.00%
Deferred Tax Assets / Liabilities
0.00
0.90
-0.90
-100.00%
Other Long Term Liabilities
45.00
1.80
43.20
2,400.00%
Long Term Trade Payables
2.44
0.00
2.44
0.00%
Long Term Provisions
3.06
0.13
2.93
2,253.85%
Total Non-Current Liabilities
211.75
2.83
208.92
7,382.33%
Current Liabilities
Trade Payables
18.15
8.96
9.19
102.57%
Other Current Liabilities
33.63
4.43
29.20
659.14%
Short Term Borrowings
50.96
30.38
20.58
67.74%
Short Term Provisions
0.79
0.00
0.79
0.00%
Total Current Liabilities
103.53
43.76
59.77
136.59%
Total Liabilities
169.04
174.45
-5.41
-3.10%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
314.11
7.13
306.98
4,305.47%
Less: Accumulated Depreciation
168.40
0.46
167.94
36,508.70%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
145.70
6.67
139.03
2,084.41%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.24
22.07
-20.83
-94.38%
Intangible assets under development
1.85
0.00
1.85
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
25.07
-25.07
-100.00%
Long Term Loans & Advances
9.98
0.53
9.45
1,783.02%
Other Non Current Assets
0.00
0.50
-0.50
-100.00%
Total Non-Current Assets
158.78
54.84
103.94
189.53%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.03
0.00
6.03
0.00%
Sundry Debtors
0.05
89.92
-89.87
-99.94%
Cash and Bank
0.14
28.69
-28.55
-99.51%
Other Current Assets
0.47
0.91
-0.44
-48.35%
Short Term Loans and Advances
3.56
0.08
3.48
4,350.00%
Total Current Assets
10.26
119.60
-109.34
-91.42%
Net Current Assets (Including Current Investments)
-93.27
75.84
-169.11
-222.98%
Total Current Assets Excluding Current Investments
10.26
119.60
-109.34
-91.42%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
169.04
174.45
-5.41
-3.10%
Contingent Liabilities
8.47
0.00
8.47
0.00%
Total Debt
212.21
30.38
181.83
598.52%
Book Value per share (adjusted)
-67.83
23.16
-90.99
-392.88%
Annual - Borrowings
Borrowings 212.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 45.00 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 146.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024






